Searched for
SUN PHARMA USFDA INSPECTION
New labour code: 3 employee-friendly changes that could make working life easierNew labour codes and central government rules simplify employee compliance by consolidating 29 fragmented laws into a unified framework. Th...- Arunachal rolls out major deregulation drive to boost investmentArunachal Pradesh has significantly eased business regulations. The state has streamlined processes across 51 areas, including land, enviro...
- Vigilance conducts statewide inspections of ration shops, NFSA godowns in KeralaKerala Vigilance and Anti-Corruption Bureau launched 'Operation Bhakshya Suraksha'. Surprise inspections targeted NFSA godowns and ration s...
- Kashmir Medical College gears up for NMC inspection, plans 150 MBBS seats with advanced healthcare facilitiesKashmir Medical College in Srinagar is undergoing significant development. The institution is being equipped with advanced technology and m...
- Angel One settles SEBI case with ₹4.28 crore paymentAngel One has settled a securities law violation case with Sebi. The company paid ₹4.28 crore to resolve allegations of supervisory lapses....
- Hormuz may reopen, but fertiliser relief is still months away for IndiaFertiliser supplies and prices will take months to return to normal. Natural gas and petroleum derivative supplies need to resume. Ammonia ...
- Angel One settles Sebi proceedings over lapses in monitoring authorised persons, pays Rs 4.28 croreAngel One has settled Sebi's adjudication and enquiry proceedings by paying Rs 4.28 crore. The regulator had alleged supervisory and monito...
- Lucky Day and Unlucky Day of the Week (June 15–21, 2026): Gemini New Moon, Mithuna Sankranti, and Sun Enters Cancer Bring a Powerful Cosmic ResetThe week of June 15-21, 2026, features a powerful astrological shift with a Gemini New Moon and Sun transit on June 15, fostering new begin...
- CIC pulls up PNGRB over RTI reply on safety, inspections of IGL pipeline workThe Central Information Commission has criticized the Petroleum and Natural Gas Regulatory Board. This is for not properly answering a Righ...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- Sun Transit in Gemini June 2026: Communication, Opportunities & Fast-Paced Growth for Every Zodiac SignThe Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- Regulators tighten GMP oversight of pharma plantsSeveral states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...
- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
Load More
